Single-dose malaria treatment using four drugs achieves high cure rates in clinical trial

	Malaria
	The latest malaria news from News Medical

	Single-dose malaria treatment using four drugs achieves high cure rates in clinical trial Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose of a treatment that utilizes four widely available malaria drugs, according to a new study presented today at the Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

	Enhancing structural biology with microgravity-grown protein crystals Discover how growing protein crystals in microgravity environments leads to higher-resolution structures and fewer defects.

			New malaria treatment holds promise against rising drug resistance The first new malaria treatment in decades holds promise against rising drug resistance after Swiss drugmaker Novartis announced it was as effective at treating the disease as established treatments.

			Common malaria test gives too many inaccurate false-negative results An international study published in the Malaria Journal claims that a widely used test for detecting malaria is delivering too many inaccurate false-negative results and is “not fit for purpose”.

			Egypt achieves milestone in eliminating trachoma as a public health problem The World Health Organization (WHO) today announced that Egypt has successfully eliminated trachoma as a public health problem, marking a historic public health milestone for the country and WHO's Eastern Mediterranean Region (WHO EMR). It is the seventh country in WHO EMR to achieve this milestone.

	Clinical trial confirms ivermectin safety in very young children down to 5 kg Millions of very young children currently excluded from treatment with the drug ivermectin could be safely included in ongoing campaigns against challenging and often neglected tropical diseases such as intestinal worms, scabies and river blindness, according to results from a clinical trial presented today at the Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

	Hidden role of biliverdin reductase A in fighting oxidative damage According to a new study from Johns Hopkins Medicine, the enzyme biliverdin reductase A (BVRA) protects neurons directly from oxidative stress, regardless of whether it produces the yellow pigment bilirubin.

	Enzyme BVRA found to shield neurons from oxidative stress New research from Johns Hopkins Medicine shows that the enzyme biliverdin reductase A (BVRA) plays a direct protective role against oxidative stress in neurons, independent of its role producing the yellow pigment bilirubin.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025